Clinical Scorecard: Multiparametric Cardiac Magnetic Resonance Without Contrast Enhances Detection of Coronary Microvascular Dysfunction and Structural Impairment Following Percutaneous Coronary Intervention
At a Glance
Category
Detail
Condition
Coronary microvascular obstruction (CMVO) following acute myocardial infarction (AMI) treated with percutaneous coronary intervention (PCI)
Key Mechanisms
CMVO caused by prolonged ischemia, distal embolic dispersion, reperfusion injury, and individual susceptibility leading to microvascular dysfunction
Target Population
Patients with acute myocardial infarction undergoing PCI within 24 hours of onset
Care Setting
Hospital setting with access to cardiac magnetic resonance imaging (CMR) and PCI facilities
Key Highlights
CMVO is associated with poor prognosis including increased cardiac death and major adverse cardiovascular events despite successful PCI.
Conventional coronary angiography does not adequately detect CMVO; cardiac magnetic resonance (CMR) with gadolinium contrast is the current standard but limited by renal dysfunction.
Multiparametric CMR without contrast can noninvasively diagnose CMVO, providing a safer alternative for patients with renal impairment.
Guideline-Based Recommendations
Diagnosis
Use multiparametric CMR including cine imaging, T2 and T2* mapping without contrast to detect CMVO in patients post-PCI.
Confirm CMVO presence by identifying hypo-intense regions on early gadolinium enhancement (EGE) and late gadolinium enhancement (LGE) images when contrast is used.
Employ the American Heart Association 16-segment model for localization of CMVO areas on CMR.
Management
Perform PCI within 24 hours of AMI onset to reduce ischemic time and potential microvascular damage.
Monitor and manage risk factors such as hypertension, diabetes, dyslipidemia, and smoking to improve outcomes.
Monitoring & Follow-up
Assess left ventricular volumes and function (LVEDVi, LVESVi, LVEF) using cine CMR imaging.
Use feature-tracking software to measure circumferential strain (CS) for evaluating myocardial function.
Monitor renal function (eGFR) to determine suitability for gadolinium contrast administration.
Risks
Renal dysfunction limits use of gadolinium contrast in CMR, necessitating non-contrast imaging techniques.
Patients with acute myocardial infarction undergoing PCI, excluding those with severe renal impairment (eGFR < 30).
Early PCI combined with multiparametric CMR imaging without contrast can improve detection of CMVO and guide prognosis without risking contrast-induced nephropathy.
Clinical Best Practices
Conduct multiparametric CMR including cine, T2, and T2* mapping prior to contrast administration for comprehensive myocardial assessment.
Use experienced cardiac radiologists and cardiologists for CMR interpretation to accurately diagnose CMVO.
Record comprehensive clinical parameters including cardiovascular risk factors and procedural timings (onset to balloon, door to balloon) to contextualize imaging findings.
New US cardiovascular statistics document persistent gaps in prevention and treatment across hypertension, diabetes, obesity, and cholesterol management, with marked disparities by age, income, and race.
